131 related articles for article (PubMed ID: 1576184)
1. [Prevalence of anti-mumps IgG antibodies in a pediatric population].
Suárez J; Castañeda MR; Gutiérrez C; Tascón R; Rodríguez EF
Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):130-4. PubMed ID: 1576184
[TBL] [Abstract][Full Text] [Related]
2. [Immunity coverage against measles, rubella and parotiditis viruses in a juvenile population in Leon, Spain].
Suárez J; Castañeda MR; Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Rodríguez Ferri EF
Med Clin (Barc); 1993 Oct; 101(13):484-7. PubMed ID: 8231381
[TBL] [Abstract][Full Text] [Related]
3. [Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].
Gil Miguel A; Astasio Arbiza P; Ortega Molina P; Domínguez Rojas V; González López A
An Esp Pediatr; 1999 May; 50(5):459-62. PubMed ID: 10394183
[TBL] [Abstract][Full Text] [Related]
4. The 2001 serological survey in the Czech Republic--mumps.
Mrázová M; Smelhausová M; Sestáková Z; Svandová E; Benes C
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S50-3. PubMed ID: 15080260
[TBL] [Abstract][Full Text] [Related]
5. [Mumps epidemic in vaccinated children in West Switzerland].
Ströhle A; Eggenberger K; Steiner CA; Matter L; Germann D
Schweiz Med Wochenschr; 1997 Jun; 127(26):1124-33. PubMed ID: 9312835
[TBL] [Abstract][Full Text] [Related]
6. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004.
Atrasheuskaya AV; Kulak MV; Rubin S; Ignatyev GM
Clin Microbiol Infect; 2007 Jul; 13(7):670-6. PubMed ID: 17484765
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.
Glikmann G; Petersen I; Mordhorst CH
Dan Med Bull; 1988 Apr; 35(2):185-7. PubMed ID: 3359817
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
Sultana R; Rahman MM; Hassan Z; Hassan MS
Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
[TBL] [Abstract][Full Text] [Related]
9. Mumps outbreak in a highly vaccinated school population: assessment of secondary vaccine failure using IgG avidity measurements.
Park DW; Nam MH; Kim JY; Kim HJ; Sohn JW; Cho Y; Song KJ; Kim MJ
Vaccine; 2007 Jun; 25(24):4665-70. PubMed ID: 17498856
[TBL] [Abstract][Full Text] [Related]
10. Mumps in Poland since 1990 to 2003; epidemiology and antibody prevalence.
Janaszek-Seydlitz W; Bucholc B; Gorska P; Slusarczyk J
Vaccine; 2005 Apr; 23(21):2711-6. PubMed ID: 15780717
[TBL] [Abstract][Full Text] [Related]
11. Horizontal transmission of the Leningrad-3 live attenuated mumps vaccine virus.
Atrasheuskaya AV; Neverov AA; Rubin S; Ignatyev GM
Vaccine; 2006 Mar; 24(10):1530-6. PubMed ID: 16266774
[TBL] [Abstract][Full Text] [Related]
12. [The benefit from mumps virus IgG antibody avidity testing in the population with high vaccine coverage in the context of other serological methods for laboratory diagnosis of mumps and the current epidemiological].
Limberková R; Smíšková D; Havlíčková M; Herrmannová K; Lexová P; Marešová V
Epidemiol Mikrobiol Imunol; 2016; 65(1):39-44. PubMed ID: 27246643
[TBL] [Abstract][Full Text] [Related]
13. [Sero-epidemiologic study of measles, rubella and mumps in the infantile population of Salamanca].
Sáenz González MC; Núñez Mateos JC; Rodrigo Sánchez N; Martín Sánchez AM
An Esp Pediatr; 1992 Apr; 36(4):293-7. PubMed ID: 1605414
[TBL] [Abstract][Full Text] [Related]
14. [Morbidity, vaccine coverage and immunity against measles, mumps and rubella in a Gallician population from 2 to 5 years old].
Vázquez Fernández E; López Rois F; Vázquez Carrete JA; Gómez Tato B; Alvarez Ares M
An Esp Pediatr; 1987 Jul; 27(1):27-31. PubMed ID: 3662251
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.
Avijgan M; Habibian R; Kheiri S
East Mediterr Health J; 2009; 15(2):295-301. PubMed ID: 19554975
[TBL] [Abstract][Full Text] [Related]
16. Sero-epidemiology of hepatitis E virus (HEV) in urban and rural children of North India.
Mathur P; Arora NK; Panda SK; Kapoor SK; Jailkhani BL; Irshad M
Indian Pediatr; 2001 May; 38(5):461-75. PubMed ID: 11359972
[TBL] [Abstract][Full Text] [Related]
17. [Vaccine coverage and levels of protection with triple viral vaccine in a children population].
Sánchez Serrano LP; Corcuera MT; Molina MP; de Miguel C; Lozano J; Oñorbe JA; Barberá G
Enferm Infecc Microbiol Clin; 1990; 8(6):384-7. PubMed ID: 2081176
[TBL] [Abstract][Full Text] [Related]
18. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
19. Detection of secondary mumps vaccine failure by means of avidity testing for specific immunoglobulin G.
Sanz-Moreno JC; Limia-Sánchez A; García-Comas L; Mosquera-Gutiérrez MM; Echevarria-Mayo JE; Castellanos-Nadal A; de Ory-Manchón F
Vaccine; 2005 Sep; 23(41):4921-5. PubMed ID: 15996797
[TBL] [Abstract][Full Text] [Related]
20. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
